EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities

Kay K Myo Min, Charlie B Ffrench iD, Claire F Jessup, Mia Shepherdson iD, Savio George Barreto iD, Claudine S Bonder iD

Cancers · 18.04.2023 · 15 (8) · 2354

DOI: 10.3390/cancers15082354 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.04.2023. Verfasst von Kay K Myo Min und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, PanKind, NHMRC Ideas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An overabundance of desmoplasia in the tumour microenvironment (TME) is one of the defining features that influences pancreatic ductal adenocarcinoma (PDAC) development, progression, metastasis, and treatment resistance. Desmoplasia is characterised by the recruitment and activation of fibroblasts, heightened extracellular matrix deposition (ECM) and reduced blood supply, as well as increased inflammation through an influx of inflammatory cells and cytokines, creating an intrinsically immunosuppressive TME with low immunogenic potential. Herein, we review the development of PDAC, the drivers that initiate and/or sustain the progression of the disease and the complex and interwoven nature of the cellular and acellular components that come together to make PDAC one of the most aggressive and difficult to treat cancers. We review the challenges in delivering drugs into the fortress of PDAC tumours in concentrations that are therapeutic due to the presence of a highly fibrotic and immunosuppressive TME. Taken together, we present further support for continued/renewed efforts focusing on aspects of the extremely dense and complex TME of PDAC to improve the efficacy of therapy for better patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

desmoplasiaimmunotherapypancreatic ductal adenocarcinomatargeted therapytumour microenvironment

Autor:innen und Institutionen

  • Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.
  • College of Medicine & Public Health, Flinders University, Bedford Park, SA 5042, Australia.
  • Adelaide Medical School, University of Adelaide, Adelaide, SA 5000, Australia.
  • Hepatopancreatobiliary & Liver Transplant Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, SA 5042, Australia.

ORCID-Profile: Charlie B Ffrench, Mia Shepherdson, Savio George Barreto, Claudine S Bonder

Förderung

  • National Health and Medical Research Council
  • PanKind
  • NHMRC Ideas
  • Flinders Foundation

Zitieren

APA

Myo Min, K. K., Ffrench, C. B., Jessup, C. F., Shepherdson, M., Barreto, S. G., & Bonder, C. S. (2023). Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities. Cancers, 15(8), 2354. https://doi.org/10.3390/cancers15082354

Vancouver

Myo Min KK, Ffrench CB, Jessup CF, Shepherdson M, Barreto SG, Bonder CS. Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities. Cancers. 2023;15(8):2354. doi:10.3390/cancers15082354

BibTeX
@article{MyoMin2023,
  author = {Myo Min, Kay K and Ffrench, Charlie B and Jessup, Claire F and Shepherdson, Mia and Barreto, Savio George and Bonder, Claudine S},
  title = {Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {2354},
  doi = {10.3390/cancers15082354}
}
Kostenlos starten →